- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03232801
A Mindfulness-based Intervention for Older Women With Low Sexual Desire
October 11, 2022 updated by: Holly Thomas, University of Pittsburgh
The overall aim of this research is to adapt and pilot test a multi-component, mindfulness-based behavioral intervention for women age 50 and older with low sexual desire.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Specifically, the investigators will conduct a pilot randomized controlled trial to assess the feasibility, acceptability, and preliminary efficacy of the intervention.
Fifty women will be randomized to the mindfulness intervention or an educational control group.
Both groups will be conducted in 3 sessions over 6 weeks in groups of 10 women.
Feasibility, acceptability, facilitators, and barriers will be assessed by surveys after each session and after intervention completion.
Preliminary efficacy will be assessed by measures of sexual desire, sexual function, and overall sexual satisfaction at 6 and 12 weeks.
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- meet criteria for a diagnosis of Female Sexual Interest/Arousal Disorder
- English-speaking
- have a current sexual partner with whom they are or would like to be sexually active
Exclusion Criteria:
- active major depression
- active substance abuse
- current intimate partner violence
- partner with active major depression
- partner with active major substance abuse
- significant relationship dissatisfaction
- current use of antidepressants
- untreated dyspareunia (sexual pain)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: mindfulness group
A multicomponent group-based intervention rooted in mindfulness, administered in 3 sessions over 6 weeks
|
A group-based, multicomponent behavioral intervention rooted in mindfulness
|
|
ACTIVE_COMPARATOR: educational group
A general midlife health and aging educational group, administered in 3 sessions over 6 weeks
|
A general health and aging education group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility - Number of Enrolled Women Participating in All Sessions
Time Frame: 6 weeks
|
Number of enrolled women participating in all sessions
|
6 weeks
|
|
Acceptability - Number of Women Indicating "Somewhat" or "Very Satisfied" on a 5-point Likert Scale Measure of Intervention Satisfaction
Time Frame: 6 weeks
|
Number of women indicating "somewhat" or "very satisfied" on a 5-point Likert scale measure of intervention satisfaction
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in FSFI Desire Score
Time Frame: Baseline and 12 weeks
|
Change in Female Sexual Function Index (FSFI) desire score from baseline to 12 weeks.
The FSFI Desire score is a subscale of the FSFI.
Scores range from 1.0 to 5.0, with higher scores indicating worse sexual desire.
Minimum score is 1.0 and maximum score is 5.0.
|
Baseline and 12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Overall Sexual Function
Time Frame: Baseline and 12 weeks
|
Total Female Sexual Function Index (FSFI) score from baseline to 12 weeks.
The FSFI score can range from 2.0 to 36.0, and a higher score indicates worse sexual function.
|
Baseline and 12 weeks
|
|
Comprehensive Sexual Desire
Time Frame: 6 weeks and 12 weeks
|
Sexual Interest and Desire Inventory (SIDI)
|
6 weeks and 12 weeks
|
|
Sexual Distress
Time Frame: 6 weeks and 12 weeks
|
Female Sexual Distress Scale - Revised (FSDS-R)
|
6 weeks and 12 weeks
|
|
Quality of Life - SF 36
Time Frame: 6 weeks and 12 weeks
|
Quality of life as measured by Short Form-36 (SF-36)
|
6 weeks and 12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 8, 2020
Primary Completion (ACTUAL)
September 1, 2021
Study Completion (ACTUAL)
September 1, 2021
Study Registration Dates
First Submitted
March 10, 2017
First Submitted That Met QC Criteria
July 25, 2017
First Posted (ACTUAL)
July 28, 2017
Study Record Updates
Last Update Posted (ACTUAL)
October 13, 2022
Last Update Submitted That Met QC Criteria
October 11, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO15060240
- K23AG052628 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexual Dysfunction
-
NYU Langone HealthNot yet recruitingSexual Dysfunction | Urinary DysfunctionUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedSexual Dysfunction | Pregnancy Related | Postpartum Sexual DysfunctionTurkey
-
London Metropolitan UniversityBarts & The London NHS Trust; Homerton University Hospital NHS Foundation TrustNot yet recruitingSexual Dysfunction
-
BayerCompletedSexual Dysfunction | Male Erectile DysfunctionBelgium, Italy, France, Germany, Spain, Netherlands, South Africa
-
University of MichiganThe Craig H. Neilsen Foundation; International Society for the Study of Women...CompletedFemale Sexual Dysfunction | Female Sexual Dysfunction Due to Physical ConditionUnited States
-
Stony Brook UniversityCompletedFemale Sexual DysfunctionUnited States
-
McGill University Health Centre/Research Institute...RecruitingInfertility | Sexual Behavior | Sexual Function | Assisted Reproductive Techniques | Sexual Dysfunction Female | Sexual Dysfunction and Infertility | Infertility Assisted Reproductive TechnologyCanada
-
Cairo UniversityCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedGynecologic Cancer | Sexual DysfunctionUnited States
Clinical Trials on mindfulness-based multicomponent intervention
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain
-
Singapore General HospitalCompletedDepression | Stroke | Stress | AnxietySingapore
-
Montreal Heart InstituteCompletedNeurodegenerative Diseases | Primary Progressive Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Non-fluent AphasiaCanada
-
University of BarcelonaUniversity of Pittsburgh; Germans Trias i Pujol Hospital; Fundació La Marató... and other collaboratorsCompleted
-
Jordan University of Science and TechnologyCompleted
-
Hospital Miguel ServetCompleted
-
Jordan University of Science and TechnologyNot yet recruitingEnd-Stage Kidney DiseaseJordan
-
Universidad Autonoma de Baja CaliforniaEnrolling by invitationAnxiety Depression (Mild or Not Persistent)Mexico
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted